Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant Center.
Lloyd R, Nikolousis E, Kishore B, Lovell R, Shankara P, Zeid NA, Horgan C, Panteliadou AK, McIlroy G, Xenou E, Kaparou M, Holder K, Murthy V, Kanellopoulos A. Lloyd R, et al. Among authors: nikolousis e. Cell Transplant. 2020 Jan-Dec;29:963689720950641. doi: 10.1177/0963689720950641. Cell Transplant. 2020. PMID: 32806929 Free PMC article.
Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience.
Horgan C, Elmoamly S, McIlroy G, Davies D, Kaparou M, Giles H, Xenou E, Kishore B, Lovell R, Nikolousis E, Shankara P, Kanellopoulos A. Horgan C, et al. Among authors: nikolousis e. Leuk Lymphoma. 2019 Dec;60(12):3075-3077. doi: 10.1080/10428194.2019.1607323. Epub 2019 May 13. Leuk Lymphoma. 2019. PMID: 31079514 No abstract available.
Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease.
Kinsella FAM, Inman CF, Gudger A, Chan YT, Murray DJ, Zuo J, McIlroy G, Nagra S, Nunnick J, Holder K, Wall K, Griffiths M, Craddock C, Nikolousis E, Moss P, Malladi R. Kinsella FAM, et al. Among authors: nikolousis e. Leuk Res. 2019 Aug;83:106173. doi: 10.1016/j.leukres.2019.106173. Epub 2019 Jun 18. Leuk Res. 2019. PMID: 31276965
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT.
Hernández-Boluda JC, Pereira A, Zinger N, Gras L, Martino R, Nikolousis E, Finke J, Chinea A, Rambaldi A, Robin M, Saccardi R, Natale A, Snowden JA, Tsirigotis P, Vallejo C, Wulf G, Xicoy B, Russo D, Maertens J, Daguindau E, Lenhoff S, Hayden P, Czerw T, McLornan DP, Yakoub-Agha I. Hernández-Boluda JC, et al. Among authors: nikolousis e. Bone Marrow Transplant. 2022 Mar;57(3):416-422. doi: 10.1038/s41409-021-01553-x. Epub 2022 Jan 23. Bone Marrow Transplant. 2022. PMID: 35066569
Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT.
Machowicz R, Suarez F, Wiktor-Jedrzejczak W, Eikema DJ, de Wreede LC, Blok HJ, Isaksson C, Einsele H, Poiré X, van Dorp S, Nikolousis E, Johansson JE, Kobbe G, Zecca M, Arnold R, Gerbitz A, Finke J, Díez-Martín JL, Bonifazi F, McQuaker G, Lenhoff S, Rohrlich PS, Theobald M, Ljungman P, Collin M, Albert MH, Ehninger G, Carlson K, Halaburda K, Lehmberg K, Schönland S, Yakoub-Agha I, Gennery AR, Lankester AC, Kröger N. Machowicz R, et al. Among authors: nikolousis e. Bone Marrow Transplant. 2022 May;57(5):817-823. doi: 10.1038/s41409-022-01634-5. Epub 2022 Mar 24. Bone Marrow Transplant. 2022. PMID: 35332305
Management of Allogeneic Stem Cell Transplantation for High-Risk AML following SARS-CoV-2 Associated Pancytopenia with Marked Bone Marrow Biopsy Alterations.
Kaparou M, Rudzki Z, Giles H, Murthy V, Srinath S, Lloyd R, Ahmed MZ, Salhan B, Chauhan S, Kishore B, Lovell R, Horgan C, Paneesha S, Xenou E, Lokare A, Ewing J, Dassanayake H, Nikolousis E, Kanellopoulos A. Kaparou M, et al. Among authors: nikolousis e. Case Rep Hematol. 2021 Jan 21;2021:8843063. doi: 10.1155/2021/8843063. eCollection 2021. Case Rep Hematol. 2021. PMID: 33510919 Free PMC article.
Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation.
McIlroy G, Nikolousis E, Abou-Zeid N, Shankara P, Kishore B, Kaparou M, Lovell R, Elmoamly S, Davies D, Horgan C, Shenouda A, Kanellopoulos A. McIlroy G, et al. Among authors: nikolousis e. Leuk Lymphoma. 2020 Jan;61(1):202-205. doi: 10.1080/10428194.2019.1650177. Epub 2019 Aug 11. Leuk Lymphoma. 2020. PMID: 31402762 No abstract available.
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study.
Styczyński J, Tridello G, Xhaard A, Medinger M, Mielke S, Taskinen M, Blijlevens N, Rodriguez MAB, Solano C, Nikolousis E, Biffi A, Groll AH, Junghanss C, Tsirigotis P, Lioure B, Šrámek J, Holler E, Galaverna F, Fagioli F, Knelange N, Wendel L, Gil L, de la Camara R, Mikulska M, Ljungman P. Styczyński J, et al. Among authors: nikolousis e. Bone Marrow Transplant. 2021 May;56(5):1171-1179. doi: 10.1038/s41409-020-01166-w. Epub 2020 Dec 7. Bone Marrow Transplant. 2021. PMID: 33288863
Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia.
Kanellopoulos A, Kaparou M, Xenou E, Paneesha S, Kishore B, Lovell R, Holder K, Suhr J, Baker L, Ryan L, Nikolousis E. Kanellopoulos A, et al. Among authors: nikolousis e. Bone Marrow Transplant. 2018 Dec;53(12):1518-1521. doi: 10.1038/s41409-018-0297-z. Epub 2018 Aug 16. Bone Marrow Transplant. 2018. PMID: 30116019
39 results